1,755 filings
Page 29 of 88
SC TO-C
zzvbljzbkze 3a08
30 Mar 15
Information about tender offer
12:00am
6-K
118e93 z6zp8i
30 Mar 15
Teva Reinforces Leadership Position in CNS with Acquisition of Auspex
12:00am
3
hyoyvwc2t7vw81 4hg5f
27 Mar 15
Initial statement of insider ownership
12:00am
6-K
7zhmfaceawrvisrldfv
24 Mar 15
Teva Announces Pricing of€2 Billion of Senior Notes
12:00am
6-K
czy5u 5ycm328pog
23 Mar 15
Teva Announces New Head of Business Development, Strategy and Innovation
12:00am
6-K
b3vvsr1rkqattv1g5t
23 Mar 15
Live Filing
12:00am
6-K
4k8 bx00j433xz
17 Mar 15
Teva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from Teva
12:00am
6-K
coj8x8ecjacyeuz 4gg
11 Mar 15
Live Filing
12:00am
6-K
e883hm elb
5 Mar 15
Teva to Present at theBarclays Global Healthcare Conference
12:00am
6-K
53s2kzamb7 fcoaw3p5
2 Mar 15
Teva Announces Sale of Sellersville, PA Facility
12:00am
6-K
ttcnv
27 Feb 15
Live Filing
12:00am
6-K
d0nfx3pcgi
26 Feb 15
Teva to Present at theCowen & Company 35th Annual Healthcare Conference
12:00am
6-K
8r34uffx4xv
25 Feb 15
Live Filing
12:00am
6-K
4u4sifxcm6 3j2o5z2
24 Feb 15
TEVA ANNOUNCES POSITIVE RESULTS FOR TEV-48125 IN PHASE IIb CHRONIC MIGRAINE STUDY MEETING PRIMARY AND SECONDARY ENDPOINTS
12:00am
6-K
5pvdva7c94zd
23 Feb 15
Live Filing
12:00am
6-K
yo3ef0kfvl14
20 Feb 15
Teva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and Immunology
12:00am
6-K
j8i6g4nnlcc6fh5
17 Feb 15
Teva Bolsters Injectable Portfolio with Launch of Generic Lovenox® and Generic Zyvox® In the United States
12:00am
6-K
hxkzhk565j7h99kwpp
17 Feb 15
Teva and Eagle Pharmaceuticals Announce Teva’s License to Commercialize Eagle’s Bendamustine Rapid Infusion Product
12:00am
SC 13G/A
0yjmwm2xe76sqyfahuw8
13 Feb 15
Teva Pharmaceutical Industries LTD
12:00am
6-K
gpot2x18m5xoey laf
12 Feb 15
Teva Announces $1 Billion Debt Tender Offer
12:00am